Quarterly report · Q3
3034.TEDINET S100SVU6
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥134.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥170.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥126.1bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥5.7bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥6.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥6.5bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.1bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥6.5bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.1bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥115.9bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥101.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥105.5bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥64.2bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥53.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥51.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥47.3bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥23.2bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥101.47 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.64 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.57 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.43 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.8% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥373m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥373m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥2.7bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥123.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥123.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥76m |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥7.6bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥11.6bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥11.3bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥296m |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥884m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥134.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥134.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥373m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥8.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥317m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥317m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥2.6bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥115.4bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥115.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥66m |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥11.1bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.8bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥250m |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥126.4bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥126.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥317m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥9.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -21000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -21000000 | JPY |
| Investments and other assets | Prior1YearInstant | 7791000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 15596000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 57689000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 65994000000 | JPY |
| Bond issuance cost da | Prior1YearInstant | 1000000 | JPY |
| Bond issuance cost da | CurrentQuarterInstant | - | JPY |
| Deferred assets | Prior1YearInstant | 1000000 | JPY |
| Deferred assets | CurrentQuarterInstant | - | JPY |
| Assets | Prior1YearInstant | 101905000000 | JPY |
| Assets | CurrentQuarterInstant | 115922000000 | JPY |
| Accounts payable trade | Prior1YearInstant | 19958000000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 26133000000 | JPY |
| Short term loans payable | Prior1YearInstant | - | JPY |
| Short term loans payable | CurrentQuarterInstant | 7500000000 | JPY |
| Current portion of bonds | Prior1YearInstant | 608000000 | JPY |
| Current portion of bonds | CurrentQuarterInstant | - | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 8104000000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 7055000000 | JPY |
| Income taxes payable | Prior1YearInstant | 1976000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 495000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 2310000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 1217000000 | JPY |
| Other cl | Prior1YearInstant | 3371000000 | JPY |
| Other cl | CurrentQuarterInstant | 4366000000 | JPY |
| Current liabilities | Prior1YearInstant | 36330000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 46767000000 | JPY |
| Long term loans payable | Prior1YearInstant | 14038000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 14827000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 306000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 303000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 34000000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 30000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 829000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 845000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 1055000000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 1093000000 | JPY |
| Other ncl | Prior1YearInstant | 455000000 | JPY |
| Other ncl | CurrentQuarterInstant | 378000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 16719000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 17478000000 | JPY |
| Liabilities | Prior1YearInstant | 53049000000 | JPY |
| Liabilities | CurrentQuarterInstant | 64246000000 | JPY |
| Capital stock | Prior1YearInstant | 5786000000 | JPY |
| Capital stock | CurrentQuarterInstant | 5786000000 | JPY |
| Capital surplus | Prior1YearInstant | 11276000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 11276000000 | JPY |
| Retained earnings | Prior1YearInstant | 34355000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 36923000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |